Dr Taylor on the Integration of Tagraxofusp Into the Frontline Treatment Armamentarium for BPDCN
April 10th 2023Justin W. Taylor, MD, discusses the evolution of frontline treatment options for patients with blastic plasmacytoid dendritic cell neoplasm, including the integration of tagraxofusp-erzs into the treatment armamentarium in this disease space.
Read More
Dr. Taylor on Ongoing Phase II Trial of Frontline Vemurafenib Combo in Hairy Cell Leukemia
October 25th 2019Justin Taylor, MD, discusses the design of an ongoing phase II clinical trial evaluating the combination of frontline vemurafenib plus obinutuzumab in patients with hairy cell leukemia.
Read More